Mammalian Genome

, 18:617

Microarray analysis of gene expression of mouse hepatocytes of different ploidy

  • Pin Lu
  • Sandrine Prost
  • Helen Caldwell
  • Jonathan D. Tugwood
  • Graham R. Betton
  • David J. Harrison
Article

Abstract

Polyploidisation in hepatocytes has been associated with many physiologic and pathologic processes such as proliferation, metabolism, regeneration, aging, and cancer. We studied gene expression patterns in hepatocytes of different ploidy. Primary hepatocytes were obtained from mice of different ages: young (4–6 weeks old), adult (8–10 weeks old), and older (22–24 weeks old). Diploid (2N), tetraploid (4N), and octoploid (8N) hepatocytes were isolated for studies using a high-density mouse genome microarray. No major changes of gene expression patterns between hepatocytes of different ploidy were found. Fifty genes were identified as differentially expressed in the diploid and tetraploid populations, but the changes were less than twofold either way. Four genes (Gas2, Igfbp2, Nr1i3, and Ccne2) were differentially expressed in tetraploid and octoploid cells. This was confirmed in two age groups, “adult” and “older,” but once again the factors were less than twofold and the expressions of Gas2 and Igfbp2 were more different between age groups than between ploidy classes. Our results show that polyploid hepatocytes are stable and “normal” without aberrant gene expression, unlike what is thought for cancer cells. By contrast to megakaryocytes, hepatocyte polyploidisation is not a differentiation step associated with major changes in gene expression. Our data support the hypothesis that hepatocyte polyploidisation is a protective mechanism against oxidative stress that occurs via a controlled process throughout growth and aging where binucleation is important.

References

  1. Adams KL, Wendel JF (2005) Novel patterns of gene expression in polyploid plants. Trends Genet 21:539–543PubMedCrossRefGoogle Scholar
  2. Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ III, et al. (2004) A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J Bone Miner Res 19:1075–1083PubMedCrossRefGoogle Scholar
  3. Anatskaya OV, Vinogradov AE (2007) Genome multiplication as adaptation to tissue survival: evidence from gene expression in mammalian heart and liver. Genomics 89:70–80PubMedCrossRefGoogle Scholar
  4. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL (2001) Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12:1315–1328PubMedGoogle Scholar
  5. Arnerlöv C, Emdin SO, Cajander S, Bengtsson NO, Tavelin B, et al. (2001) Intratumoral variations in DNA ploidy and s-phase fraction in human breast cancer. Anal Cell Pathol 23:21–28PubMedGoogle Scholar
  6. Barbason H, Van Cantfort J, Houbrechts N (1974) Correlation between tissue and division fuctions in the liver of young rats. Cell Tissue Kinet 7:319–326PubMedGoogle Scholar
  7. Bellamy COC, Clarke AR, Wyllie AH, Harrison DJ (1997) p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J 11:591–599PubMedGoogle Scholar
  8. Benetti R, Del Sal G, Monte M, Paroni G, Brancolini C, et al. (2001) The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis. EMBO J 20:2702–2714PubMedCrossRefGoogle Scholar
  9. Bohm N, Noltemeyer N (1981) Excessive reversible phenobarbital induced nuclear DNA-polyplodization in the growing mouse liver. Histochemistry 72:63–74PubMedCrossRefGoogle Scholar
  10. Brancolini C, Bottega S, Schneider C (1992) Gas2, a growth arrest-specific protein, is a component of the microfilament network system. J Cell Biol 117:1251–1261PubMedCrossRefGoogle Scholar
  11. Bucher NLR (1963) Regeneration of the mammalian liver. Liver Int Rev Cytol 15:245–300Google Scholar
  12. Chabicovsky M, Herkner K, Rossmanith W (2003) Overexpression of activin βC or activin βE in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of hepatic cells. Endocrinology 144:3497–3504PubMedCrossRefGoogle Scholar
  13. Chen YG, Liu HM, Lin SL, Lee JM, Ying SY (2002) Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med 227:75–87Google Scholar
  14. Chipchase MD, O’Neill M, Melton DW (2003) Characterisation of premature liver polyploidy in DNA repair (Ercc1)-deficient mice. Hepatology 38:958–966PubMedGoogle Scholar
  15. Cimini D, Tanzarella C, Degrassi F (1999) Differences in malsegregation rates obtained by scoring ana-telophase or binucleated cells. Mutagenesis 14:563–568PubMedCrossRefGoogle Scholar
  16. Dallman PR, Spirito RA, Siimes MA (1974) Diurnal patterns of DNA synthesis in the rat: modification by diet and feeding schedule. J Nutr 104:1234–1241PubMedGoogle Scholar
  17. Fujikawa-Yamamoto K, Zong ZP, Murakami M, Odashima S, Ikeda T, et al. (1997) Spontaneous polyploidization results in apoptosis in a Meth-A tumor cell line. Cell Struct Funct 22:399–405PubMedCrossRefGoogle Scholar
  18. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, et al. (1996) 17p(p53)allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett’s esophagus. Proc Natl Acad Sci U S A 93:7081–7084PubMedCrossRefGoogle Scholar
  19. Galitski T, Saldanha AJ, Styles CA, Lander ES, Fink GR (1999) Ploidy regulation of gene expression. Science 285:251–254PubMedCrossRefGoogle Scholar
  20. Gerhard HB, Schultze B, Maurer W (1971) Cell classes and ploidy distribution of isolated mouse liver cells. Exp Cell Res 69:223–226PubMedCrossRefGoogle Scholar
  21. Glotzer M (2005) The molecular requirements for cytokinesis. Science 307:1735–1739PubMedCrossRefGoogle Scholar
  22. Gorla GR, Malhi H, Gupta S (2001) Polyploidy associated with oxidative injury attenuates proliferative potential of cells. J Cell Sci 114:2943–2951PubMedGoogle Scholar
  23. Grellier P, Berrebi D, Peuchmaur M, Babajko S (2002) The IGF system in neuroblastoma xenografts: focus on IGF-binding protein-6. J Endocrinol 172:467–476PubMedCrossRefGoogle Scholar
  24. Guidotti JE, Bregerie O, Robert A, Debey P, Brechot C, et al. (2003) Liver cell polyploidisation: A pivotal role for binuclear hepatocytes. J Biol Chem 278:19095–19101PubMedCrossRefGoogle Scholar
  25. Gupta S (2000) Hepatic polyploidy and liver growth control. Semin Cancer Biol 10:161–171PubMedCrossRefGoogle Scholar
  26. Hasmall SC, Roberts RA (1997) Hepatic ploidy, nuclearity, and distribution of DNA synthesis: a comparison of nongenotoxic hepatocarciogens with noncarcinogenic liver mitogens. Toxicol Appl Pharmacol 144:287–293PubMedCrossRefGoogle Scholar
  27. Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, et al. (1994) Induction of apoptosis in the murine liver with recombinant human activin-A. Hepatology 20:854–862PubMedCrossRefGoogle Scholar
  28. Jones MR, Ravid K (2004) Vascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expression. J Biol Chem 279:5306–5313PubMedCrossRefGoogle Scholar
  29. Kirschner K, Singh R, Prost S, Melton DW (2007) Characterisation of ERCC1 deficiency in the liver and conditional ERCC1-deficient primary hepatocytes in vitro. DNA Repair (Amst) 6:304–316CrossRefGoogle Scholar
  30. Kudryavtasev BN, Kudryavtseva MV, Sakuta GA, Stein GI (1993) Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch B Cell Pathol Incl Mol Pathol 64:387–393CrossRefGoogle Scholar
  31. Levine DS, Sanchez CA, Rabinovitch PS, Reid BJ (1991) Formation of the tetraploid intermediates is associated with the development of cells with more than four centrioles in the elastase-simian virus 50 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci U S A 88:6427–6431PubMedCrossRefGoogle Scholar
  32. Margolis RL, Lohez OD, Andreassen PR (2003) G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 88:673–683PubMedCrossRefGoogle Scholar
  33. Minamishima YA, Nakayama K, Nakayama KI (2002) Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice. Cancer Res 62:995–999PubMedGoogle Scholar
  34. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, et al. (2002) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122–15127CrossRefGoogle Scholar
  35. Möröy T, Geisen C (2004) Cyclin E. Intl J Biochem Cell Biol 36:1424–1439CrossRefGoogle Scholar
  36. Pascussi JM, Gerbal-Chaloin S, Drocourt L, Maurel P, Vilarem MJ (2003) The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619:243–253PubMedGoogle Scholar
  37. Quarrie JK, Riabowol KT (2004) Murine models of life span extension. Sci Aging Knowledge Environ 31:re5CrossRefGoogle Scholar
  38. Rajvanshi P, Liu D, Ott M, Gapandeep S, Schilsky M, et al. (1998) Ploidy-based fractionation of rat hepatocytes with varying metabolic potential, proliferative capacity and retroviral gene transfer. Exp Cell Res 244:405–419PubMedCrossRefGoogle Scholar
  39. Raslova H, Kauffmann A, Sekkai D, Ripoche H, Larbret F, et al. (2007) Interrelation between polyploidization and megakaryocyte differentiation: a gene profiling approach. Blood 109:3225–3234PubMedCrossRefGoogle Scholar
  40. Roh M, Song C, Kim J, Abdulkadir SA (2005) Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1. J Biol Chem 280:40568–40577PubMedCrossRefGoogle Scholar
  41. Rosenzweig SA (2004) What’s new in the IGF-binding proteins? Growth Horm IGF Res 14:329–336PubMedCrossRefGoogle Scholar
  42. Saeter G, Lee CZ, Schwarze PE, Ous S, Chen DS, et al. (1988) Changes in ploidy distributions in human-liver carcinogenesis. J Natl Cancer Inst 80:1480–1485PubMedCrossRefGoogle Scholar
  43. Sanz N, Diezfernandez C, Fernandezsimon L, Alvarez A, Cascales M (1995) Relationship between antioxidant systems, intracellular thiols and DNA-ploidy in liver of rats during experimental cirrhogenesis. Carcinogenesis 16:1585–1593PubMedCrossRefGoogle Scholar
  44. Schmucker DL (1998) Aging and the liver. J Gerontol Ser A Biol Sci Med Sci 53:B315–B320Google Scholar
  45. Seglen PO (1997) DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival. Cell Biol Toxicol 13:301–315PubMedCrossRefGoogle Scholar
  46. Shimokawa I, Higami Y, Tsuchiya T, Otani H, Komatsu T, et al. (2003) Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction. FASEB J 17:1108–1109PubMedGoogle Scholar
  47. Sigal SH, Rajvanshi P, Gorla GR, Sokhi RP, Saxena R, et al. (1999) Partial hepatectomy-induced polyploidy attenuates hepatocytes replication and activates cell aging events. Am J Physiol Gastrointest Liver Physiol 276:G1260–G1272Google Scholar
  48. Storchova Z, Pellman D (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5:45–54PubMedCrossRefGoogle Scholar
  49. Swales K, Negishi M (2004) CAR, driving into the future. Mol Endocrinol 18:1589–1598PubMedCrossRefGoogle Scholar
  50. Torres S, Diaz BP, Cabrera JJ, Diaz-Chico JC, Diaz-Chico BN, et al. (1999) Thyroid hormone regulation of rat hepatocyte proliferation and polyploidization. Am J Physiol Gastrointest Liver Physiol 276:G155–G163Google Scholar
  51. Toyoda H, Bregerie O, Vallet A, Nalpas B, Pivert G, et al. (2005) Changes to hepatocyte ploidy and binuclearity profiles during human chronic viral hepatitis. Gut 54:297–302PubMedCrossRefGoogle Scholar
  52. Vendrell E, Morales C, Risques R, Capella G, Peinado MA (2005) Genomic determinants of prognosis in colorectal cancer. Cancer Lett 221:1–9PubMedCrossRefGoogle Scholar
  53. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, et al. (1993) Activin-A – an autocrine inhibitor of initiation of DNA-synthesis in rat hepatocytes. J Clin Invest 92:1491–1496PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Pin Lu
    • 1
  • Sandrine Prost
    • 1
    • 3
  • Helen Caldwell
    • 1
  • Jonathan D. Tugwood
    • 2
  • Graham R. Betton
    • 2
  • David J. Harrison
    • 1
  1. 1.Pathology Division, School of Molecular and Clinical MedicineUniversity of EdinburghEdinburghUK
  2. 2.Molecular Toxicology GroupSafety Assessment UK, AstraZeneca PharmaceuticalsCheshireUK
  3. 3.The Queen’s Medical Research InstituteUniversity of EdinburghEdinburghUK

Personalised recommendations